Difference between revisions of "Maryanne Demasi"
(stub) |
m (tidy) |
||
Line 29: | Line 29: | ||
==Background== | ==Background== | ||
− | Demasi completed a doctorate in medical research at the [[University of Adelaide]] and worked for a decade at the [[Royal Adelaide Hospital]] as a [[research scientist]] specialising in [[rheumatoid arthritis]] research. She has also worked as an advisor to the [[South Australia|South Australian Government's]] Department of Further Education, Employment, Science and Technology | + | Demasi completed a doctorate in medical research at the [[University of Adelaide]] and worked for a decade at the [[Royal Adelaide Hospital]] as a [[research scientist]] specialising in [[rheumatoid arthritis]] research. She has also worked as an advisor to the [[South Australia|South Australian Government's]] Department of Further Education, Employment, Science and Technology. |
==Catalyst== | ==Catalyst== |
Revision as of 22:24, 11 November 2022
Maryanne Demasi (journalist, scientist, Medical dissident) | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nationality | Australian | |||||||||||||||
Alma mater | University of Adelaide | |||||||||||||||
Interests | • statins • Wi-Fi • 5G | |||||||||||||||
|
Maryanne Demasi is an Australian science reporter and presenter, best known for her work with the Australian Broadcasting Corporation (ABC) Catalyst television program, where she was fired after pressure from Big Pharma.
Background
Demasi completed a doctorate in medical research at the University of Adelaide and worked for a decade at the Royal Adelaide Hospital as a research scientist specialising in rheumatoid arthritis research. She has also worked as an advisor to the South Australian Government's Department of Further Education, Employment, Science and Technology.
Catalyst
Demasi became nationally prominent for television stories[1] criticizing the use of statins, and possible health effects from low level microvawe exposure from Wi-Fi and mobile phones. The backlash from Big Pharma and the medical establishment led to a "reorganization" of Catalyst.[2]